Evonik and DSM to Launch Animal Nutrition Joint Venture

Royal DSM and Evonik announced plans Wednesday to create a joint venture to develop omega-3 fatty acid animal nutrition products from algae and construct a new production facility in the United States.

“This breakthrough innovation will, for the first time, enable the production of omega-3 fatty acids for animal nutrition without using fish oil from wild caught fish, a finite resource,” said a press release issued by the firms. “Evonik and DSM’s alternative omega-3 source is the first to offer both EPA and DHA and will be aimed at initial applications in salmon aquaculture and pet food.”

DSM Nutritional Products and Evonik Nutrition & Care will each hold a 50% stake in the venture, set to be headquartered in the Netherlands under the name Veramaris. The companies said that some $200 million will be invested in the construction of the co-owned production facility, which is projected to become operational by 2019. An existing Evonik site in the U.S. will be the location of the new facility, the release said.

“The initial annual production capacity will meet roughly 15% of the current annual demand for EPA and DHA by the salmon aquaculture industry,” the joint release said.

Under an existing partnership agreement, the companies developed a pilot-scale quantity of the algal oil at Evonik’s Kingstree, SC manufacturing facility, enabling delivery of product to customers while the construction of the new facility gets underway.

Click here for information about the PBS Toronto event, May 16-18, 2017

For more articles, news, and equipment reviews, visit our Equipment Zones